JP2012072106A5 - - Google Patents

Download PDF

Info

Publication number
JP2012072106A5
JP2012072106A5 JP2010245227A JP2010245227A JP2012072106A5 JP 2012072106 A5 JP2012072106 A5 JP 2012072106A5 JP 2010245227 A JP2010245227 A JP 2010245227A JP 2010245227 A JP2010245227 A JP 2010245227A JP 2012072106 A5 JP2012072106 A5 JP 2012072106A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
caffeine
loxoprofen
methylephedrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010245227A
Other languages
Japanese (ja)
Other versions
JP5798734B2 (en
JP2012072106A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2010245227A priority Critical patent/JP5798734B2/en
Priority claimed from JP2010245227A external-priority patent/JP5798734B2/en
Publication of JP2012072106A publication Critical patent/JP2012072106A/en
Publication of JP2012072106A5 publication Critical patent/JP2012072106A5/ja
Application granted granted Critical
Publication of JP5798734B2 publication Critical patent/JP5798734B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (9)

ロキソプロフェン又はその塩、エフェドリン類及びカフェインを含有し、剤形が固形製剤である医薬組成物。 A pharmaceutical composition comprising loxoprofen or a salt thereof, ephedrines and caffeine and having a solid dosage form . ロキソプロフェン又はその塩が、ロキソプロフェンナトリウム水和物である請求項１記載の医薬組成物。   The pharmaceutical composition according to claim 1, wherein the loxoprofen or a salt thereof is loxoprofen sodium hydrate. ロキソプロフェンナトリウム水和物を、ロキソプロフェンナトリウム無水物換算で、１０〜３００ｍｇを１日量として含有する請求項２記載の医薬組成物。   The pharmaceutical composition according to claim 2, comprising loxoprofen sodium hydrate as a daily dose of 10 to 300 mg in terms of loxoprofen sodium anhydride. エフェドリン類が、ｌ−メチルエフェドリン塩酸塩、ｄｌ−メチルエフェドリン塩酸塩、ｌ−メチルエフェドリンサッカリン塩、ｄｌ−メチルエフェドリンサッカリン塩、プソイドエフェドリン塩酸塩及びプソイドエフェドリン硫酸塩から選ばれる１種以上である請求項１〜３いずれか１項記載の医薬組成物。   The ephedrine is at least one selected from 1-methylephedrine hydrochloride, dl-methylephedrine hydrochloride, 1-methylephedrine saccharin salt, dl-methylephedrine saccharin salt, pseudoephedrine hydrochloride and pseudoephedrine sulfate. The pharmaceutical composition according to any one of -3. エフェドリン類が、ｄｌ−メチルエフェドリン塩酸塩である請求項１〜４いずれか１項記載の医薬組成物。   The pharmaceutical composition according to any one of claims 1 to 4, wherein the ephedrine is dl-methylephedrine hydrochloride. エフェドリン類を、５〜５００ｍｇを１日量として含有する請求項１〜５いずれか１項記載の医薬組成物。   The pharmaceutical composition according to any one of claims 1 to 5, which contains 5 to 500 mg of ephedrine as a daily dose. カフェインが、カフェイン水和物、無水カフェイン、安息香酸ナトリウムカフェイン及びクエン酸カフェインから選ばれる１種以上である請求項１〜６いずれか１項記載の医薬組成物。 The pharmaceutical composition according to any one of claims 1 to 6 , wherein the caffeine is at least one selected from caffeine hydrate, anhydrous caffeine, sodium benzoate caffeine and caffeine citrate. カフェインを、１０〜１０００ｍｇを１日量として含有する請求項１〜７いずれか１項記載の医薬組成物。 The pharmaceutical composition according to any one of claims 1 to 7 , comprising 10 to 1000 mg of caffeine as a daily dose. 請求項１〜８いずれか１項記載の医薬組成物と乾燥剤とを容器中に含む医薬製剤。 A pharmaceutical preparation comprising the pharmaceutical composition according to any one of claims 1 to 8 and a desiccant in a container.
JP2010245227A 2009-10-30 2010-11-01 Loxoprofen-containing pharmaceutical composition Active JP5798734B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010245227A JP5798734B2 (en) 2009-10-30 2010-11-01 Loxoprofen-containing pharmaceutical composition

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2009250953 2009-10-30
JP2009250953 2009-10-30
JP2010193774 2010-08-31
JP2010193774 2010-08-31
JP2010245227A JP5798734B2 (en) 2009-10-30 2010-11-01 Loxoprofen-containing pharmaceutical composition

Publications (3)

Publication Number Publication Date
JP2012072106A JP2012072106A (en) 2012-04-12
JP2012072106A5 true JP2012072106A5 (en) 2013-12-19
JP5798734B2 JP5798734B2 (en) 2015-10-21

Family

ID=46168714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010245227A Active JP5798734B2 (en) 2009-10-30 2010-11-01 Loxoprofen-containing pharmaceutical composition

Country Status (1)

Country Link
JP (1) JP5798734B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6197231B2 (en) * 2012-12-13 2017-09-20 シオノギヘルスケア株式会社 Loxoprofen-containing pharmaceutical composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3481052B2 (en) * 1996-06-05 2003-12-22 三洋電機株式会社 Solid preparation supply device and desiccant used in solid preparation supply device
JP2986433B2 (en) * 1997-08-21 1999-12-06 株式会社ピーエムシーコーポレーション Pill bottle buffer mat
JP4936579B2 (en) * 1997-09-05 2012-05-23 第一三共株式会社 Loxoprofen-containing pharmaceutical preparation
JPH11206849A (en) * 1998-01-29 1999-08-03 Dai Ichi Seiyaku Co Ltd Drug drying body and drug packaging body
JP4357016B2 (en) * 1998-11-06 2009-11-04 第一三共株式会社 Pharmaceutical composition containing loxoprofen
JP2000290199A (en) * 1999-03-31 2000-10-17 Taisho Pharmaceut Co Ltd Oral medicinal composition
JP2001233765A (en) * 2000-02-24 2001-08-28 Ss Pharmaceut Co Ltd Drug for common cold
JP2002316927A (en) * 2001-04-19 2002-10-31 Taisho Pharmaceut Co Ltd Composition for common cold
JP2003261442A (en) * 2002-03-11 2003-09-16 Toyo Capsule Kk Soft capsule preparation containing pseudoephedrine hydrochloride
JP2007314517A (en) * 2006-04-27 2007-12-06 Daiichi Sankyo Healthcare Co Ltd Antitussive or expectorant pharmaceutical composition comprising loxoprofen
EP2109570A1 (en) * 2007-01-20 2009-10-21 Merck Patent GmbH Packaging containing soft capsules
JP5006900B2 (en) * 2009-04-16 2012-08-22 第一三共株式会社 Pharmaceutical composition containing dl-methylephedrine hydrochloride

Similar Documents

Publication Publication Date Title
JP2012255026A5 (en)
HRP20171175T1 (en) Novel tricyclic compounds
JP2015515475A5 (en)
JP2009537554A5 (en)
JP2013542247A5 (en)
EA201071204A1 (en) DRONEDARON APPLICATION FOR THE PREPARATION OF A MEDICINE FOR THE APPLICATION IN THE PREVENTION OF HOSPITALIZATION IN THE CARDIOLOGICAL DEPARTMENT OR MORTALITY
JP2012031131A5 (en)
JP2012502037A5 (en)
JP2011201907A5 (en)
JP2013509429A5 (en)
JP2014218522A5 (en)
HRP20171648T1 (en) Substituted piperidyl-ethyl-pyrimidine as ghrelin o-acyl transferase inhibitor
GB2495676A (en) Use of binders for manufacturing storage stable formulations
JP2011522896A5 (en)
JP2012031147A5 (en)
UA109421C2 (en) PHARMACEUTICAL COMPOSITION CONTAINING SIGMA-RECEPTOR LIGANDS
JP2013507408A5 (en)
JP2011527299A5 (en)
EA201300053A1 (en) PHOSPHATE CONTAINING PREPARATION FOR CONVENIENT RECEPTION
EP3228311A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
JP2018039810A5 (en)
JP2006342148A5 (en)
TR201001417A1 (en) Cefdinir formulation with improved dissolution rate
JP2011068692A5 (en)
WO2014006636A3 (en) Stable compositions of fesoterodine